{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:25:29Z","timestamp":1790767529256,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003088","name":"Evangelisches Studienwerk Villigst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2014.152.1"],"award-info":[{"award-number":["2014.152.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA 1550\/12-1"],"award-info":[{"award-number":["MA 1550\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejca.2019.03.021","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T07:55:37Z","timestamp":1558338937000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Breast cancer, placenta and pregnancy"],"prefix":"10.1016","volume":"115","author":[{"given":"Karolin","family":"Froehlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Isabell","family":"Heger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boodor","family":"Al-Kawlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Anna","family":"Aberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo Rudolf","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2019.03.021_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","article-title":"Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study","volume":"27","author":"Stensheim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000136002","article-title":"New therapeutic options for breast cancer during pregnancy","volume":"3","author":"Loibl","year":"2008","journal-title":"Breast Care"},{"key":"10.1016\/j.ejca.2019.03.021_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-0-387-75115-3_20","article-title":"Adjuvant therapy in patients with breast cancer during pregnancy","volume":"151","author":"Loibl","year":"2009","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(11)61092-1","article-title":"Breast cancer in pregnancy","volume":"379","author":"Amant","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2019.03.021_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cncr.21610","article-title":"Breast carcinoma during pregnancy. International recommendations from an expert meeting","volume":"106","author":"Loibl","year":"2006","journal-title":"Cancer."},{"key":"10.1016\/j.ejca.2019.03.021_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","article-title":"Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes","volume":"28","author":"Van Calsteren","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02782194","article-title":"Pregnancy-associated breast cancer: a case-control study in a young population with a high-fertility rate","volume":"17","author":"Ibrahim","year":"2000","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib8","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1067\/mob.2001.114867","article-title":"Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997","volume":"184","author":"Smith","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2019.03.021_bib9","first-page":"1143","article-title":"Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan","volume":"83","author":"Ishida","year":"1992","journal-title":"Jpn J Canc Res : Gann"},{"key":"10.1016\/j.ejca.2019.03.021_bib10","first-page":"280","article-title":"Worse survival in breast cancer among women with recent childbirth: results from a Swedish population-based register study","volume":"4","author":"Bladstrom","year":"2003","journal-title":"Clin Breast Canc"},{"key":"10.1016\/j.ejca.2019.03.021_bib11","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/j.suronc.2011.06.002","article-title":"Cancer and pregnancy: a comprehensive review","volume":"20","author":"Voulgaris","year":"2011","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib12","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1016\/j.ejca.2012.10.004","article-title":"The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer","volume":"48","author":"Cardoso","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.03.021_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archsurg.138.1.91","article-title":"Breast cancer in pregnancy: a literature review","volume":"138","author":"Woo","year":"2003","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejca.2019.03.021_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0002-9378(92)91334-7","article-title":"Maternal and fetal outcome after breast cancer in pregnancy","volume":"166","author":"Zemlickis","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2019.03.021_bib15","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/cncr.21070","article-title":"Women age < or = 35 years with primary breast carcinoma: disease features at presentation","volume":"103","author":"Gonzalez-Angulo","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2019.03.021_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccr.2006.02.026","article-title":"Pregnancy and breast cancer: the other side of the coin","volume":"9","author":"Polyak","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2019.03.021_bib17","first-page":"420","article-title":"Biological and pathological features in pregnancy-associated breast cancer: a matched case-control study","volume":"36","author":"Baulies","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0019-509X.138285","article-title":"Pregnancy associated breast cancer: an institutional experience","volume":"51","author":"Gogia","year":"2014","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.ejca.2019.03.021_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.breast.2012.05.002","article-title":"Pregnancy-associated breast cancers: do they differ from other breast cancers in young women?","volume":"21","author":"Genin","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2019.03.021_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13058-014-0427-5","article-title":"Biology of breast cancer in young women","volume":"16","author":"Azim","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ctrv.2005.04.010","article-title":"The pregnant mother with breast cancer: diagnostic and therapeutic management","volume":"31","author":"Pavlidis","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2019.03.021_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/cncr.11614","article-title":"Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features","volume":"98","author":"Middleton","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2019.03.021_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10549-015-3479-z","article-title":"Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials","volume":"152","author":"Loibl","year":"2015","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejca.2019.03.021_bib24","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1200\/JCO.2012.45.6335","article-title":"Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study","volume":"31","author":"Amant","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S1470-2045(12)70261-9","article-title":"Treatment of breast cancer during pregnancy: an observational study","volume":"13","author":"Loibl","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib26","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/ajmg.a.32432","article-title":"Pierre Robin sequence associated with first trimester fetal tamoxifen exposure","volume":"146A","author":"Berger","year":"2008","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ejca.2019.03.021_bib27","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.ajog.2009.02.017","article-title":"Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios","volume":"201","author":"Beale","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2019.03.021_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000341820","article-title":"Taxanes during pregnancy: probably safe, but still to be optimized","volume":"83","author":"Berveiller","year":"2012","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2019.03.021_bib29","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/annonc\/mdn553","article-title":"Chemotherapy for breast cancer during pregnancy: is epirubicin safe?","volume":"19","author":"Mir","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/annonc\/mdp517","article-title":"Taxanes for breast cancer during pregnancy: a systematic review","volume":"21","author":"Mir","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib31","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1208\/ps020320","article-title":"Human membrane transporter database: a Web-accessible relational database for drug transport studies and pharmacogenomics","volume":"2","author":"Yan","year":"2000","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.ejca.2019.03.021_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.placenta.2005.09.001","article-title":"Designing pregnancy centered medications: drugs which do not cross the human placenta","volume":"27","author":"Gedeon","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.ejca.2019.03.021_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","article-title":"Placental drug transporters and their role in fetal protection","volume":"33","author":"Iqbal","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.ejca.2019.03.021_bib34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cbi.2013.03.007","article-title":"Placental ABC transporters, cellular toxicity and stress in pregnancy","volume":"203","author":"Aye","year":"2013","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.ejca.2019.03.021_bib35","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1096\/fj.07-8688com","article-title":"The ABC transporter BCRP\/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction","volume":"21","author":"Evseenko","year":"2007","journal-title":"FASEB J"},{"issue":"19","key":"10.1016\/j.ejca.2019.03.021_bib36","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1508913","article-title":"Pediatric outcome after maternal cancer diagnosed during pregnancy","volume":"373","author":"Amant","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.03.021_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0143-4004(03)00063-8","article-title":"Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury","volume":"24","author":"Lala","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.ejca.2019.03.021_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199407073310102","article-title":"Transient increase in the risk of breast cancer after giving birth","volume":"331","author":"Lambe","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.03.021_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10911-009-9119-7","article-title":"Pregnancy and breast cancer: when they collide","volume":"14","author":"Lyons","year":"2009","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2019.03.021_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/mehy.2000.1119","article-title":"The fetal antigen hypothesis: cancers and beyond","volume":"56","author":"Janerich","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ejca.2019.03.021_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6602302","article-title":"Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects","volume":"92","author":"Albrektsen","year":"2005","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejca.2019.03.021_bib42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/oxfordjournals.aje.a010266","article-title":"Age at any full-term pregnancy and breast cancer risk","volume":"151","author":"Chie","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2019.03.021_bib43","first-page":"299","article-title":"Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden)","volume":"13","author":"Liu","year":"2002","journal-title":"Cancer Causes Control CCC"},{"key":"10.1016\/j.ejca.2019.03.021_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc1839","article-title":"Pregnancy-associated breast cancer and metastasis","volume":"6","author":"Schedin","year":"2006","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.ejca.2019.03.021_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fendo.2014.00213","article-title":"Molecular pathways involved in pregnancy-induced prevention against breast cancer","volume":"5","author":"Barton","year":"2014","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ejca.2019.03.021_bib46","first-page":"2257","article-title":"Does pregnancy immunize against breast cancer?","volume":"55","author":"Agrawal","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib47","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2014-2360","article-title":"Gene expression profile induced by pregnancy in the breast of premenopausal women","volume":"74","author":"Santucci-Pereira","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/eji.1830260207","article-title":"CC chemokines induce the generation of killer cells from CD56+ cells","volume":"26","author":"Maghazachi","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ejca.2019.03.021_bib49","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0888-7543(90)90485-D","article-title":"Localization of a human T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12","volume":"6","author":"Donlon","year":"1990","journal-title":"Genomics"},{"key":"10.1016\/j.ejca.2019.03.021_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","article-title":"Dendritic cells: specialized and regulated antigen processing machines","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2019.03.021_bib51","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1126\/science.8266077","article-title":"Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor","volume":"262","author":"Noguchi","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ejca.2019.03.021_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0167-5699(94)90148-1","article-title":"Human CD38: a glycoprotein in search of a function","volume":"15","author":"Malavasi","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.ejca.2019.03.021_bib53","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","article-title":"Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins","volume":"315","author":"Luster","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2019.03.021_bib54","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2019.03.021_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.182.1.155","article-title":"Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in\u00a0vivo","volume":"182","author":"Angiolillo","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejca.2019.03.021_bib56","first-page":"55","article-title":"Detection of placental protein five (PP5) and pregnancy-specific glycoprotein (SP1) in benign and malignant breast disease","volume":"2","author":"Bremner","year":"1981","journal-title":"Oncodev Biol Med"},{"key":"10.1016\/j.ejca.2019.03.021_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/jrf.0.0890033","article-title":"Cellular origin and induction of pregnancy-associated alpha 2-glycoprotein synthesis in pregnant rats","volume":"89","author":"Dell'Uomo","year":"1990","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.ejca.2019.03.021_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.2910310203","article-title":"Pregnancy-associated alpha 2 glycoprotein (alpha 2 PAG) synthesis by human breast cancer tissue and cultured cell lines","volume":"31","author":"Sarcione","year":"1983","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2019.03.021_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/gyno.1998.4988","article-title":"Immune recognition of endometrial tumor antigens induced by multiparity","volume":"70","author":"Katsanis","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib60","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/107155769700400606","article-title":"Induction of immune responses to ovarian tumor antigens by multiparity","volume":"4","author":"Shields","year":"1997","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.ejca.2019.03.021_bib61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-9877(94)90059-0","article-title":"The fetal antigen hypothesis for breast cancer, revisited","volume":"43","author":"Janerich","year":"1994","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ejca.2019.03.021_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2217\/imt.10.17","article-title":"MUC1 immunotherapy","volume":"2","author":"Beatson","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ejca.2019.03.021_bib63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-2776(04)82006-6","article-title":"MUC1 immunobiology: from discovery to clinical applications","volume":"82","author":"Vlad","year":"2004","journal-title":"Adv Immunol"},{"key":"10.1016\/j.ejca.2019.03.021_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1020360121451","article-title":"MUC1 and the immunobiology of cancer","volume":"7","author":"Taylor-Papadimitriou","year":"2002","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejca.2019.03.021_bib65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pupt.2011.12.003","article-title":"Role of epithelial mucins during airway infection","volume":"25","author":"Kim","year":"2012","journal-title":"Pulm Pharmacol Therapeut"},{"key":"10.1016\/j.ejca.2019.03.021_bib66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0014-4827(90)90174-9","article-title":"Determination of apical membrane polarity in mammary epithelial cell cultures: the role of cell-cell, cell-substratum, and membrane-cytoskeleton interactions","volume":"188","author":"Parry","year":"1990","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib67","doi-asserted-by":"crossref","first-page":"542152","DOI":"10.1155\/2013\/542152","article-title":"Mucins help to avoid alloreactivity at the maternal fetal interface","volume":"2013","author":"Redzovic","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.ejca.2019.03.021_bib68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0897.2009.00792.x","article-title":"Inflammation and implantation","volume":"63","author":"Dekel","year":"2010","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"10.1016\/j.ejca.2019.03.021_bib69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s002620050344","article-title":"A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis","volume":"43","author":"Jerome","year":"1997","journal-title":"Cancer Immunol Immunotherapy: CII"},{"key":"10.1016\/j.ejca.2019.03.021_bib70","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00418-002-0383-5","article-title":"Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in\u00a0vitro","volume":"117","author":"Jeschke","year":"2002","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ejca.2019.03.021_bib71","first-page":"571","article-title":"Human fetal ductal plate revisited: II. MUC1, MUC5AC, and MUC6 are expressed in human fetal ductal plate and MUC1 is expressed also in remodeling ductal plate, remodeled ductal plate and mature bile ducts of human fetal livers","volume":"6","author":"Terada","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.ejca.2019.03.021_bib72","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1369\/jhc.2009.952085","article-title":"The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding","volume":"57","author":"Jeschke","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.ejca.2019.03.021_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1012220902991","article-title":"Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women","volume":"69","author":"Croce","year":"2001","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejca.2019.03.021_bib74","first-page":"1911","article-title":"Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk","volume":"24","author":"Cramer","year":"2013","journal-title":"Cancer Causes Control: CCC"},{"key":"10.1016\/j.ejca.2019.03.021_bib75","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1073\/pnas.86.18.7159","article-title":"Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells","volume":"86","author":"Barnd","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.ejca.2019.03.021_bib76","first-page":"2908","article-title":"Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells","volume":"51","author":"Jerome","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib77","first-page":"R4","article-title":"3rd International workshop on carcinoma-associated mucins, August 7-11 1994, Cambridge, UK","volume":"12","author":"Brockhausen","year":"1995","journal-title":"Glycoconj J"},{"key":"10.1016\/j.ejca.2019.03.021_bib78","doi-asserted-by":"crossref","DOI":"10.1089\/jwh.152460901750269643","article-title":"Sex of first child and breast cancer survival in young women","author":"Olson","year":"2015","journal-title":"J Wom Health (Larchmt)"},{"key":"10.1016\/j.ejca.2019.03.021_bib79","first-page":"26","article-title":"Gender of the first offspring, age at diagnosis, and survival with breast cancer (Utah, United States)","volume":"5","author":"Janerich","year":"1994","journal-title":"Cancer Causes Control: CCC"},{"key":"10.1016\/j.ejca.2019.03.021_bib80","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ijc.2910600311","article-title":"Multiple births, sex of children and subsequent breast-cancer risk for the mothers: a prospective study in Norway","volume":"60","author":"Albrektsen","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2019.03.021_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(99)00435-8","article-title":"Pregnancy induced mammary tumor specific effector cells are present long after parturition in a breast cancer model in rats","volume":"154","author":"Chakravarty","year":"2000","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2019.03.021_bib82","first-page":"5795","article-title":"The induction of in\u00a0vivo proliferation of long-lived CD44hi CD8+ T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice","volume":"58","author":"Belardelli","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib83","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/bjc.1988.88","article-title":"Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy","volume":"57","author":"Sinha","year":"1988","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejca.2019.03.021_bib84","first-page":"1351","article-title":"Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma","volume":"6","author":"Saito","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib85","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/11383","article-title":"Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1","volume":"5","author":"Nakashima","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2019.03.021_bib86","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ygyno.2006.05.047","article-title":"Clinical significance of RCAS1 as a biomarker of uterine cancer","volume":"103","author":"Sonoda","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib87","first-page":"623","article-title":"Clinical significance of RCAS1 as a biomarker of ovarian cancer","volume":"17","author":"Sonoda","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejca.2019.03.021_bib88","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0897.2007.00575.x","volume":"59","author":"Dutsch-Wicherek","year":"2008","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"10.1016\/j.ejca.2019.03.021_bib89","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000086824","article-title":"The Role of RCAS1 and oxytocinase in immune tolerance during pregnancy","volume":"20","author":"Wicherek","year":"2005","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ejca.2019.03.021_bib90","first-page":"561","article-title":"The level of maternal immune tolerance and fetal maturity","volume":"26","author":"Wicherek","year":"2005","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.ejca.2019.03.021_bib91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejogrb.2005.05.019","article-title":"The molecular changes during placental detachment","volume":"125","author":"Wicherek","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejca.2019.03.021_bib92","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-0897.2007.00540.x","article-title":"RCAS1 decidual immunoreactivity and RCAS1 serum level during cesarean section with respect to the progression of labor","volume":"59","author":"Wicherek","year":"2008","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"10.1016\/j.ejca.2019.03.021_bib93","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0002-9378(86)90090-6","article-title":"Immunologic factors contributing to the initiation of labor--lymphocyte reactivity in term labor and threatened preterm delivery","volume":"155","author":"Szekeres-Bartho","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2019.03.021_bib94","doi-asserted-by":"crossref","first-page":"e1016700","DOI":"10.1080\/2162402X.2015.1016700","article-title":"Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells","volume":"4","author":"Wu","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejca.2019.03.021_bib95","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jri.2007.05.001","article-title":"The human tumor-associated antigen RCAS1 in pregnancies complicated by pre-eclampsia","volume":"77","author":"Tskitishvili","year":"2008","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ejca.2019.03.021_bib96","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1501::AID-CNCR12>3.0.CO;2-3","article-title":"A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas","volume":"77","author":"Sonoda","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2019.03.021_bib97","doi-asserted-by":"crossref","first-page":"22998","DOI":"10.1074\/jbc.M301361200","article-title":"The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens","volume":"278","author":"Engelsberg","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2019.03.021_bib98","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1126\/science.6729450","article-title":"T and Tn, general carcinoma autoantigens","volume":"224","author":"Springer","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ejca.2019.03.021_bib99","series-title":"Role of EBAG9 in COPI-dependent glycoprotein maturation and secretion processes in tumor cells","author":"Wolf","year":"2010"},{"key":"10.1016\/j.ejca.2019.03.021_bib100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1593\/neo.07259","article-title":"Antibodies to placental immunoregulatory ferritin with transfer of polyclonal lymphocytes arrest MCF-7 human breast cancer growth in a nude mouse model","volume":"9","author":"Halpern","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejca.2019.03.021_bib101","first-page":"1581","article-title":"Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors","volume":"25","author":"Jeschke","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib102","first-page":"1079","article-title":"Glycodelin A - a famous lipocalin and its role in breast cancer","volume":"34","author":"Kolbl","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib103","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1158\/1078-0432.CCR-14-2464","article-title":"Glycodelin: a new biomarker with immunomodulatory functions in non-small cell lung cancer","volume":"21","author":"Schneider","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib104","doi-asserted-by":"crossref","first-page":"278591","DOI":"10.1155\/2015\/278591","article-title":"Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study","volume":"2015","author":"Uysal","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ejca.2019.03.021_bib105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/molehr\/5.4.372","article-title":"Relaxin stimulates glycodelin mRNA and protein concentrations in human endometrial glandular epithelial cells","volume":"5","author":"Tseng","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ejca.2019.03.021_bib106","doi-asserted-by":"crossref","first-page":"17101","DOI":"10.1074\/jbc.M010451200","article-title":"Purification and characterization of an immunomodulatory endometrial protein, glycodelin","volume":"276","author":"Vigne","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2019.03.021_bib107","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s004180000196","article-title":"Immunohistochemical analysis of steroid receptors and glycodelin A (PP14) in isolated glandular epithelial cells of normal human endometrium","volume":"114","author":"Mylonas","year":"2000","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ejca.2019.03.021_bib108","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/molehr\/gam081","article-title":"Glycodelin blocks progression to S phase and inhibits cell growth: a possible progesterone-induced regulator for endometrial epithelial cell growth","volume":"14","author":"Ohta","year":"2008","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ejca.2019.03.021_bib109","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/molehr\/6.8.681","article-title":"Nitric oxide induces apoptosis in the human\u00a0corpus luteum in\u00a0vitro","volume":"6","author":"Vega","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ejca.2019.03.021_bib110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1369\/jhc.2008.950600","article-title":"Glycodelin protein and mRNA is downregulated in human first trimester abortion and partially upregulated in mole pregnancy","volume":"56","author":"Toth","year":"2008","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.ejca.2019.03.021_bib111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2407-12-2","article-title":"Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer","volume":"12","author":"Lenhard","year":"2012","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejca.2019.03.021_bib112","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/er.2001-0026","article-title":"Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation","volume":"23","author":"Seppala","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejca.2019.03.021_bib113","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2559.2006.02351.x","article-title":"Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues","volume":"48","author":"Jeschke","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.ejca.2019.03.021_bib114","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MED.0b013e32834c800d","article-title":"Placental hormones and the control of maternal metabolism and fetal growth","volume":"18","author":"Newbern","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ejca.2019.03.021_bib115","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1152\/physrev.00040.2011","article-title":"Evolution of placental function in mammals: the molecular basis of gas and nutrient transfer, hormone secretion, and immune responses","volume":"92","author":"Carter","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejca.2019.03.021_bib116","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejca.2010.09.007","article-title":"Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies","volume":"47","author":"Azim","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2019.03.021_bib117","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0002-9378(94)70290-X","article-title":"Survival of breast cancer patients after subsequent term pregnancy: \"healthy mother effect\"","volume":"170","author":"Sankila","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2019.03.021_bib118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/humrep\/der365","article-title":"Hormone-dependent placental manipulation of breast cancer cell migration","volume":"27","author":"Epstein Shochet","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejca.2019.03.021_bib119","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2003.12.149","article-title":"Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant","volume":"21","author":"Alexander","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib120","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3109\/10428194.2012.758844","article-title":"Establishment of a one-sided ex\u00a0vivo human placenta perfusion model to assess adhesion and invasion behavior of T cell leukemia cell lines","volume":"54","author":"Schamberger","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2019.03.021_bib121","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/humrep\/deq227","article-title":"Breast cancer characteristics are modified by first trimester human placenta: in\u00a0vitro co-culture study","volume":"25","author":"Tartakover-Matalon","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejca.2019.03.021_bib122","first-page":"573","article-title":"Extranuclear signaling by estrogen: role in breast cancer progression and metastasis","volume":"62","author":"Cortez","year":"2010","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.ejca.2019.03.021_bib123","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.steroids.2008.12.010","article-title":"Estrogen and progesterone interactive effects in postconfluent MCF-7 cell culture","volume":"74","author":"Sukocheva","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/j.ejca.2019.03.021_bib124","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1111\/febs.12533","article-title":"Harmful effect of ERbeta on BCRP-mediated drug resistance and cell proliferation in ERalpha\/PR-negative breast cancer","volume":"280","author":"Li","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.ejca.2019.03.021_bib125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2005.01.021","article-title":"Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis","volume":"231","author":"Lazennec","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2019.03.021_bib126","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.mce.2013.08.005","article-title":"Estrogen receptor beta in breast cancer","volume":"382","author":"Haldosen","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ejca.2019.03.021_bib127","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3892\/ijo.2014.2778","article-title":"Estrogen receptor beta selective agonists reduce invasiveness of triple-negative breast cancer cells","volume":"46","author":"Hinsche","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejca.2019.03.021_bib128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/1940-6207.CAPR-09-0069","article-title":"Gene expression patterns in the human breast after pregnancy","volume":"3","author":"Asztalos","year":"2010","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2004.06.038","article-title":"Growth and function of the normal human placenta","volume":"114","author":"Gude","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4644(2000)77:34+<1::AID-JCB2>3.0.CO;2-G","article-title":"Hormonal approach to breast cancer prevention","volume":"34","author":"Russo","year":"2000","journal-title":"J Cell Biochem Suppl"},{"key":"10.1016\/j.ejca.2019.03.021_bib131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mce.2006.06.015","article-title":"Human chorionic gonadotropin (hCG) and prevention of breast cancer","volume":"269","author":"Janssens","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ejca.2019.03.021_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1023351819956","article-title":"A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate","volume":"79","author":"Bodek","year":"2003","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejca.2019.03.021_bib133","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/molehr\/gap067","article-title":"Recent progress in luteinizing hormone\/human chorionic gonadotrophin hormone research","volume":"15","author":"Rahman","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ejca.2019.03.021_bib134","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mce.2008.12.016","article-title":"LH receptor gene expression is essentially absent in breast tumor tissue: implications for treatment","volume":"302","author":"Kuijper","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ejca.2019.03.021_bib135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcyt.2013.07.005","article-title":"Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy","volume":"16","author":"Niknejad","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ejca.2019.03.021_bib136","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00003226-200005000-00018","article-title":"Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane","volume":"19","author":"Hao","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.ejca.2019.03.021_bib137","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00232-014-9642-3","article-title":"Effect of amniotic membrane proteins in human cancer cell lines: an exploratory study","volume":"247","author":"Mamede","year":"2014","journal-title":"J Membr Biol"},{"key":"10.1016\/j.ejca.2019.03.021_bib138","first-page":"1153","article-title":"Reduction of tumorigenicity by placental extracts","volume":"32","author":"Marleau","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2019.03.021_bib139","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/35079135","article-title":"Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor","volume":"411","author":"Ohtaki","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2019.03.021_bib140","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3892\/ol_00000136","article-title":"Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review)","volume":"1","author":"Shoji","year":"2010","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejca.2019.03.021_bib141","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3892\/ijo.2016.3386","article-title":"Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I\/II clinical trial","volume":"48","author":"Antonilli","year":"2016","journal-title":"Int J Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919302333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919302333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:22:50Z","timestamp":1778782970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919302333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":141,"alternative-id":["S0959804919302333"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.03.021","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer, placenta and pregnancy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}